Need for novel vaccines
Vaccines have had a major contribution to global health and have in the past been very successful in controlling diseases. Despite this, current vaccines are unsuccessful in combating more complex pathogens that are smarter in evading the immune system. With improved technological advances vaccines can reach their potential of helping the immune system combat complex diseases in a more efficient and effective manner.
Abera has developed universal bacterial and derived OMV vaccine delivery platforms that stimulate the immune system more effectively than conventional techniques. The multivalent character of our platform allows the generation of broadly protecting vaccines that induce immunity to multiple pathogens or pathogenic variants at the same time. Importantly, Abera’s technology is compatible with needle-free administration and makes it possible to produce vaccines cheaply and quickly.